| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |